The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
Criteria Specification: CSpec Registry PDF

Variant: NM_000277.2(PAH):c.806delT (p.Ile269Thrfs)

CA229778

102844 (ClinVar)

Gene: PAH
Condition: phenylketonuria
Inheritance Mode: Autosomal recessive inheritance
UUID: f5d8dc3f-dba0-4dc9-98cd-4a22b6a11a83

HGVS expressions

NM_000277.2:c.806delT
NM_000277.2(PAH):c.806delT (p.Ile269Thrfs)
NC_000012.12:g.102852851del
CM000674.2:g.102852851del
NC_000012.11:g.103246629del
CM000674.1:g.103246629del
NC_000012.10:g.101770759del
NG_008690.1:g.69752del
NG_008690.2:g.110560del
NM_000277.1:c.806del
NM_000277.2:c.806del
NM_001354304.1:c.806del
NM_000277.3:c.806del
ENST00000307000.7:c.791del
ENST00000549247.6:n.565del
ENST00000553106.5:c.806del

Pathogenic

Met criteria codes 3
PVS1 PP4 PM2

Expert Panel

Evidence Links 1

Evidence submitted by expert panel
PAH VCEP
PAH-specific ACMG/AMP criteria applied: PVS1: Frameshift variant; PM2: Extremely low frequency. gnomAD MAF=0.00007.; PP4: Detected in a PKU patient. BH4 deficiency not assessed. (PMID:9012412). In summary this variant meets criteria to be classified as pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: (PVS1, PM2, PP4).
Met criteria codes
PVS1
Frameshift variant
PP4
Detected in a PKU patient. BH4 deficiency not assessed.

PM2
Extremely low frequency. gnomAD MAF=0.00007.
Approved on: 2018-08-10
Published on: 2019-08-17
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.